Literature DB >> 17934791

Treatment of immobilization hypercalciuria using weekly alendronate in two quadriplegic patients.

Ayce Atalay1, Nur Turhan.   

Abstract

Metabolic and urinary problems encountered in spinal cord injury patients are multifaced. We report two patients with high-level spinal cord injuries who have developed hypercalciuria after admission to the rehabilitation unit. To establish a clean intermittent self-catheterization programme, the hypercalciuria was treated successfully with alendronate. Twenty-four-hour urinary calcium excretion decreased significantly after medical treatment for hypercalciuria. Since high-level quadriplegic patients may not be mobilized in the acute phase of the rehabilitation, use of alendronate for preventing hypercalciuria and maintaining a successful clean intermittent self-catheterization programme can be considered as a supportive/complementary measure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17934791     DOI: 10.1007/s11255-007-9292-9

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  7 in total

Review 1.  Bone loss in spinal cord-injured patients: from physiopathology to therapy.

Authors:  L Maïmoun; C Fattal; J-P Micallef; E Peruchon; P Rabischong
Journal:  Spinal Cord       Date:  2006-04       Impact factor: 2.772

2.  Alendronate prevents bone loss in patients with acute spinal cord injury: a randomized, double-blind, placebo-controlled study.

Authors:  N L Gilchrist; C M Frampton; R H Acland; M G Nicholls; R L March; P Maguire; A Heard; P Reilly; K Marshall
Journal:  J Clin Endocrinol Metab       Date:  2007-01-16       Impact factor: 5.958

3.  Recurrent vesical calculi, hypercalciuria, and biochemical evidence of increased bone resorption in an adult male with paraplegia due to spinal cord injury: is there a role for intermittent oral disodium etidronate therapy for prevention of calcium phosphate bladder stones?

Authors:  S Vaidyanathan; I D Watson; O Jonsson; A Z Buczynski; F Grases; I P Heilberg; T Yasui; J J Wyndaele; K Tozawa; K Kohri; B Schurch; P L Hughes; G Singh; B M Soni; P Sett; W D Fraser
Journal:  Spinal Cord       Date:  2005-05       Impact factor: 2.772

Review 4.  Osteoporosis after spinal cord injury.

Authors:  Sheng-Dan Jiang; Li-Yang Dai; Lei-Sheng Jiang
Journal:  Osteoporos Int       Date:  2005-10-11       Impact factor: 4.507

5.  Fractures after myelopathy: the risk quantified.

Authors:  J H Frisbie
Journal:  J Spinal Cord Med       Date:  1997-01       Impact factor: 1.985

Review 6.  Osteoporosis in women with spinal cord injuries.

Authors:  S M Ott
Journal:  Phys Med Rehabil Clin N Am       Date:  2001-02       Impact factor: 1.784

7.  Prevention of hypercalciuria and stone-forming propensity during prolonged bedrest by alendronate.

Authors:  L A Ruml; S K Dubois; M L Roberts; C Y Pak
Journal:  J Bone Miner Res       Date:  1995-04       Impact factor: 6.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.